Your fact-checks will appear here
From 2020–2025 the most clearly documented tinnitus device to receive U.S. FDA clearance is Neuromod Devices’ Lenire, which earned De Novo approval in March 2023 based on the TENT‑A3 pivotal trial and...
Medically proven, widely recommended treatments for tinnitus in 2025 focus on management rather than a universal cure: cognitive behavioural therapy (CBT) and hearing-focused approaches (hearing aids,...
Dr. Mehmet Oz publicly showcased and discussed transcranial magnetic stimulation (TMS) as a treatment for depression on The Dr. Oz Show (episodes and demonstrations are noted by multiple clinic and ve...
Since 2020, the most visible FDA action on tinnitus devices in the provided reporting is the De Novo clearance/approval of Lenire, a bimodal (sound + tongue electrical) neuromodulation system: the FDA...
Neurocept appears primarily as a consumer-facing that markets capsules claiming to improve memory, focus, and mental clarity, while offering money-back guarantees and relying on ingredient lists commo...
Regulatory activity aimed at tinnitus products promoted as “cures” in the provided reporting centers on the FDA’s clearance of a formal medical device—Lenire—through a De Novo pathway and subsequent g...
Available reporting and regulatory databases in the provided sources do not mention any FDA approval, clearance, warning letter, or enforcement action specifically tied to a product named “NeuroGold.”...